By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Serenity Pharmaceuticals 



New York  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
FDA Approves Serenity’s Noctiva (Desmopressin Acetate) – The First Drug Approved For The Treatment Of Nocturia 3/7/2017 6:35:33 AM
Serenity Release: FDA Approves First Treatment For Frequent Urination At Night Due To Overproduction Of Urine 3/3/2017 7:00:01 AM
FDA Panel Expresses Concerns Over Allergan (AGN)-Serenity Drug for Nighttime Urination 10/18/2016 6:56:23 AM
CPEX Pharmaceuticals' Partner Serenity Pharmaceuticals Announces Development and Commercialization Agreement with Allergan Inc. (AGN) for Nocturia Product Candidate 4/1/2010 8:45:51 AM
Allergan Inc. (AGN) Licenses Drug for Night-Time Urination; To Pay Serenity Pharmaceuticals $43 Million Upfront; $122 Million in Future Payments 4/1/2010 8:39:29 AM
CPEX Pharmaceuticals Announces Completion of Phase 2 Trial for Urology Drug by Serenity Pharmaceuticals 2/26/2009 9:42:36 AM
CPEX Pharmaceuticals Announces Initiation of Phase II Trial for Urology Indication by Serenity Pharmaceuticals 11/17/2008 10:03:50 AM
CPEX Pharmaceuticals and Serenity Pharmaceuticals Announce Collaboration on Drug Candidate for Urology Indication 8/4/2008 8:33:10 AM
//-->